YIDU TECH (02158) authorizes the trustee to purchase shares from the market based on the stock incentive plan.

date
21:33 26/03/2026
avatar
GMT Eight
MedTech (02158) announced that the board of directors has authorized the company to appoint an independent professional trustee to purchase the company's shares on the market at the prevailing market price according to the rules of the initial public offering share incentive plan.
YIDU TECH (02158) announced that the board of directors has authorized the appointment of an independent professional trustee to purchase company shares on the market at the prevailing market price in accordance with the rules of the first public offering share incentive plan. The board believes that maintaining a reserve of shares purchased at competitive prices will enhance the group's flexibility in building an effective compensation and reward structure, thereby strengthening its ability to attract and retain talent necessary for the continued growth and development of the group. Share purchases will be made based on the company's needs and current market conditions. Any shares purchased by the trustee will be held in accordance with the trust deed constituting the first public offering share incentive plan as agreed upon by the company and the trustee. Any funds paid (if applicable) will come from the company's internal financial resources and will not impact the company's operations.